SCHEDULE: Ridgeback Capital Discloses 6.9% Stake in Semler Scientific

Ridgeback Capital Investments L.P., Ridgeback Capital Investments LLC, and Ridgeback Capital Management LLC have jointly disclosed a beneficial ownership of 6.9% in Semler Scientific, Inc., totaling 976,112 shares.

Summary

• Ridgeback Capital Investments L.P., Ridgeback Capital Investments LLC, and Ridgeback Capital Management LLC (collectively, the "Reporting Persons") have filed a Schedule 13G, indicating their beneficial ownership of Semler Scientific, Inc. common stock.
• The Reporting Persons collectively own 976,112 shares of Semler Scientific, Inc. common stock, which represents 6.9% of the company's outstanding shares.
• This beneficial ownership includes 39,247 shares that are issuable upon the conversion of convertible notes.
• The 6.9% ownership percentage is calculated based on 13,788,405 shares of common stock outstanding as of July 7, 2025, as reported by Semler Scientific in its Current Report on Form 8-K, plus an additional 300,000 shares issued to the Reporting Persons on July 11, 2025.
• The Reporting Persons hold shared voting power and shared dispositive power over all 976,112 beneficially owned shares.

Sentiment

Score: 6

Explanation: The disclosure of a significant institutional stake is generally a positive signal, indicating investor confidence, though the document itself is purely factual and does not contain explicit sentiment regarding company performance.

Positives

• A significant institutional investor, Ridgeback Capital, has taken a substantial 6.9% stake in Semler Scientific, which can be interpreted as a signal of confidence in the company's future prospects.
• The direct issuance of 300,000 shares to the Reporting Persons on July 11, 2025, indicates a direct investment and commitment from Ridgeback Capital.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a new significant institutional shareholder could be viewed positively, potentially increasing investor confidence and liquidity.
• Company Management: The new significant shareholder may seek engagement with management regarding strategic direction or corporate governance, although the filing states the shares were not acquired for the purpose of changing or influencing control, other than activities solely in connection with a nomination under Rule 14a-11.

Key Dates

Keywords

Semler Scientific, Ridgeback Capital, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, SEC Filing, Equity Stake, Convertible Notes